Opportunities for topical antimicrobial therapy: permeation of canine skin by fusidic acid
- PMID: 29162115
- PMCID: PMC5697365
- DOI: 10.1186/s12917-017-1270-6
Opportunities for topical antimicrobial therapy: permeation of canine skin by fusidic acid
Abstract
Background: Staphylococcal infection of the canine epidermis and hair follicle is amongst the commonest reasons for antimicrobial prescribing in small animal veterinary practice. Topical therapy with fusidic acid (FA) is an attractive alternative to systemic therapy based on low minimum inhibitory concentrations (MICs, commonly <0.03 mg/l) documented in canine pathogenic staphylococci, including strains of MRSA and MRSP (methicillin-resistant Staphylococcus aureus and S. pseudintermedius). However, permeation of canine skin by FA has not been evaluated in detail. This study aimed to define the degree and extent of FA permeation in canine skin in vitro from two sites with different hair follicle density following application of a licensed ophthalmic formulation that shares the same vehicle as an FA-betamethasone combination product approved for dermal application in dogs. Topical FA application was modelled using skin held in Franz-type diffusion cells. Concentrations of FA in surface swabs, receptor fluid, and transverse skin sections of defined anatomical depth were determined using high-performance liquid chromatography and ultraviolet (HPLC-UV) analysis.
Results: The majority of FA was recovered by surface swabs after 24 h, as expected (mean ± SEM: 76.0 ± 17.0%). FA was detected within 424/470 (90%) groups of serial sections of transversely cryotomed skin containing follicular infundibula, but never in 48/48 (100%) groups of sections containing only deeper follicular structures, nor in receptor fluid, suggesting that FA does not permeate beyond the infundibulum. The FA concentration (mean ± SEM) in the most superficial 240 μm of skin was 2000 ± 815 μg/g.
Conclusions: Topically applied FA can greatly exceed MICs for canine pathogenic staphylococci at the most common sites of infection. Topical FA therapy should now be evaluated using available formulations in vivo as an alternative to systemic therapy for canine superficial bacterial folliculitis.
Keywords: Canine; Fusidic acid; Pyoderma; Skin; Topical therapy.
Conflict of interest statement
Ethics approval
The Royal Veterinary College’s Clinical Research Ethical Review Board endorsed the use of cadaveric canine skin that was donated for this purpose by an approved external laboratory (2016 1651–2-R).
Consent for publication
Not applicable.
Competing interests
The authors’ group has previously received funding from Dechra Veterinary Products (DVP), Shropshire, UK, in support of laboratory research and clinical teaching of undergraduate and postgraduate students.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
References
-
- World Health Organisation. Global Action Plan on Antimicrobial Resistance. 2015. http://www.who.int/antimicrobial-resistance/publications/global-action-p.... Accessed 8 Aug 2016.
-
- Loeffler A, Linek M, Moodley A, Guardabassi L, Sung JML, Winkler M, et al. First report of multiresistant, mecA-positive Staphylococcus intermedius in Europe: 12 cases from a veterinary dermatology referral clinic in Germany. Vet Dermatol. 2007;18:412–421. doi: 10.1111/j.1365-3164.2007.00635.x. - DOI - PubMed
-
- Hillier A, Lloyd DH, Weese JS Blondeau JM, Boothe D, Breitschwerdt E, et al. Guidelines for the diagnosis and antimicrobial therapy of canine superficial bacterial folliculitis (antimicrobial guidelines working Group of the International Society for companion animal infectious diseases). Vet Dermatol 2014;25:163-e43. - PubMed
-
- Nesbitt GH. Bacterial diseases. In: Lea & Febiger, editor. Canine and feline dermatology. A systematic approach. Philadelphia: Lippincott Williams and Wilkins; 1983.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
